During the past 12 months, the average Free Cash Flow per Share Growth Rate of Nova Pharma Solutions Bhd was 1366.70% per year.
During the past 9 years, Nova Pharma Solutions Bhd's highest 3-Year average Free Cash Flow per Share Growth Rate was 30.10% per year. The lowest was 30.10% per year. And the median was 30.10% per year.
Nova Pharma Solutions Bhd Price-to-Free-Cash-Flow Historical Data
The historical data trend for Nova Pharma Solutions Bhd's Price-to-Free-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Nova Pharma Solutions Bhd Price-to-Free-Cash-Flow Chart
Competitive Comparison of Nova Pharma Solutions Bhd's Price-to-Free-Cash-Flow
For the Engineering & Construction subindustry, Nova Pharma Solutions Bhd's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nova Pharma Solutions Bhd's Price-to-Free-Cash-Flow Distribution in the Construction Industry
For the Construction industry and Industrials sector, Nova Pharma Solutions Bhd's Price-to-Free-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Nova Pharma Solutions Bhd's Price-to-Free-Cash-Flow falls into.
Nova Pharma Solutions Bhd Price-to-Free-Cash-Flow Calculation
Nova Pharma Solutions Bhd's Share Price of today is RM0.23.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Nova Pharma Solutions Bhd's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 was RM0.04.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Nova Pharma Solutions Bhd (XKLS:03006) Price-to-Free-Cash-Flow Explanation
Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.
In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.
Be Aware
In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.
Nova Pharma Solutions Bhd Price-to-Free-Cash-Flow Related Terms
Thank you for viewing the detailed overview of Nova Pharma Solutions Bhd's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.
Nova Pharma Solutions Bhd (XKLS:03006) Business Description
Nova Pharma Solutions Bhd provides engineering solutions to pharma and biotech industries. The company's reportable segments include Design fee, Post Design, & Other support fees. Design fee comprises conceptual designs which include user requirement specification, capacity analysis and process scheduling with detailed costing, list of deliverables, details specification of various equipment and processes. Post design fee comprise tendering and procurement support as well as the construction of a plant, & Other support fees comprise of services to assist a customer in the good manufacturing practice document review & gap analysis and assessment. It generates a majority of its revenue from the Design fee segment. Geographically, the company generates a majority of its revenue from Malaysia.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XKLS:03006 has been successfully added to your 